{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360292619081045120.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1080/14728222.2018.1444753"}},{"identifier":{"@type":"URI","@value":"https://www.tandfonline.com/doi/pdf/10.1080/14728222.2018.1444753"}}],"dc:title":[{"@value":"Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380292619081045120","@type":"Researcher","foaf:name":[{"@value":"Florent Amatore"}],"jpcoar:affiliationName":[{"@value":"Centre de recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Aix Marseille Université, Institut Paoli – Calmettes, Marseille, France"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619081045121","@type":"Researcher","foaf:name":[{"@value":"Laurent Gorvel"}],"jpcoar:affiliationName":[{"@value":"Centre de recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Aix Marseille Université, Institut Paoli – Calmettes, Marseille, France"}]},{"@id":"https://cir.nii.ac.jp/crid/1380292619081045248","@type":"Researcher","foaf:name":[{"@value":"Daniel Olive"}],"jpcoar:affiliationName":[{"@value":"Centre de recherche en Cancérologie de Marseille, INSERM U1068, CNRS U7258, Aix Marseille Université, Institut Paoli – Calmettes, Marseille, France"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"14728222"},{"@type":"EISSN","@value":"17447631"}],"prism:publicationName":[{"@value":"Expert Opinion on Therapeutic Targets"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2018-03","prism:volume":"22","prism:number":"4","prism:startingPage":"343","prism:endingPage":"351"},"reviewed":"false","url":[{"@id":"https://www.tandfonline.com/doi/pdf/10.1080/14728222.2018.1444753"}],"createdAt":"2018-02-22","modifiedAt":"2018-04-12","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360009142647269760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunotherapy for squamous cell carcinoma of the head and neck"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285713515397248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Perspectives of Immune Suppression in the Tumor Microenvironment Promoting Oral Malignancy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390292859816093568","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immune Checkpoint Molecules and Co-stimulatory Molecules in Cutaneous T-cell Lymphoma"},{"@language":"ja","@value":"皮膚 T 細胞リンパ腫における免疫チェックポイント分子・共刺激分子"},{"@language":"ja-Kana","@value":"ヒフ Tサイボウ リンパシュ ニ オケル メンエキ チェックポイント ブンシ ・ キョウ シゲキ ブンシ"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1080/14728222.2018.1444753"},{"@type":"CROSSREF","@value":"10.1093/jjco/hyaa139_references_DOI_TPSjsPTKc9rZ38dCS76HqpbyPjG"},{"@type":"CROSSREF","@value":"10.2174/1874210601812010455_references_DOI_TPSjsPTKc9rZ38dCS76HqpbyPjG"},{"@type":"CROSSREF","@value":"10.2336/nishinihonhifu.84.187_references_DOI_TPSjsPTKc9rZ38dCS76HqpbyPjG"}]}